KR102929869B1 - C10-알킬렌 치환된 13-원 마크로라이드 및 이의 용도 - Google Patents

C10-알킬렌 치환된 13-원 마크로라이드 및 이의 용도

Info

Publication number
KR102929869B1
KR102929869B1 KR1020217018876A KR20217018876A KR102929869B1 KR 102929869 B1 KR102929869 B1 KR 102929869B1 KR 1020217018876 A KR1020217018876 A KR 1020217018876A KR 20217018876 A KR20217018876 A KR 20217018876A KR 102929869 B1 KR102929869 B1 KR 102929869B1
Authority
KR
South Korea
Prior art keywords
optionally substituted
alkyl
group
delete delete
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217018876A
Other languages
English (en)
Korean (ko)
Other versions
KR20210133950A (ko
Inventor
로저 비. 클락
리차드 알람
웨슬리 프란시스 오스틴
필립 호간
이반 주이트
수스미타 디. 라히리
조나단 에프. 로렌스
시벤 리
수하오 시
웬잉 왕
요시타카 이치카와
앤드류 지. 마이어스
지양 장
피터 니엘스 칼센
앙드르 산체즈
가나파티 단다파니
트리무르툴루 네티팔리
엠디. 아타우르 라만
토마스 레피트레
Original Assignee
지카니 테라퓨틱스, 인크.
프레지던트 앤드 펠로우즈 오브 하바드 칼리지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102929869(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 지카니 테라퓨틱스, 인크., 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 filed Critical 지카니 테라퓨틱스, 인크.
Publication of KR20210133950A publication Critical patent/KR20210133950A/ko
Application granted granted Critical
Publication of KR102929869B1 publication Critical patent/KR102929869B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1020217018876A 2018-11-19 2019-11-18 C10-알킬렌 치환된 13-원 마크로라이드 및 이의 용도 Active KR102929869B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
US62/769,383 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (2)

Publication Number Publication Date
KR20210133950A KR20210133950A (ko) 2021-11-08
KR102929869B1 true KR102929869B1 (ko) 2026-02-23

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217018876A Active KR102929869B1 (ko) 2018-11-19 2019-11-18 C10-알킬렌 치환된 13-원 마크로라이드 및 이의 용도

Country Status (22)

Country Link
US (1) US12552825B2 (cg-RX-API-DMAC10.html)
EP (2) EP4737470A3 (cg-RX-API-DMAC10.html)
JP (2) JP7551610B2 (cg-RX-API-DMAC10.html)
KR (1) KR102929869B1 (cg-RX-API-DMAC10.html)
CN (1) CN113573779A (cg-RX-API-DMAC10.html)
AU (1) AU2019385333B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009624A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120148A1 (cg-RX-API-DMAC10.html)
DK (1) DK3883647T3 (cg-RX-API-DMAC10.html)
ES (1) ES3063764T3 (cg-RX-API-DMAC10.html)
FI (1) FI3883647T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260395T1 (cg-RX-API-DMAC10.html)
IL (1) IL283194B2 (cg-RX-API-DMAC10.html)
LT (1) LT3883647T (cg-RX-API-DMAC10.html)
MX (1) MX2021005423A (cg-RX-API-DMAC10.html)
PL (1) PL3883647T3 (cg-RX-API-DMAC10.html)
PT (1) PT3883647T (cg-RX-API-DMAC10.html)
RS (1) RS68104B1 (cg-RX-API-DMAC10.html)
SG (1) SG11202105227QA (cg-RX-API-DMAC10.html)
SI (1) SI3883647T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600094T1 (cg-RX-API-DMAC10.html)
WO (1) WO2020106627A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
JP2025530776A (ja) 2022-09-01 2025-09-17 ジカニ セラピューティクス, インコーポレイテッド 13員環マクロライドを使用した家族性大腸腺腫症の処置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
JP2004516233A (ja) * 2000-04-27 2004-06-03 ファイザー・プロダクツ・インク 哺乳動物の細菌若しくは原生動物感染症を治療するか又は予防するためのアザライド抗生組成物の使用
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-アザライド化合物
EP2588084B1 (en) * 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
EP3277701A4 (en) 2015-03-25 2019-03-06 President and Fellows of Harvard College SYNTHESIS OF DESOSAMINES
CA3000709A1 (en) * 2015-10-01 2017-04-06 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
US11673910B2 (en) * 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
IL283194B1 (en) 2024-11-01
EP3883647B1 (en) 2026-02-11
SMT202600094T1 (it) 2026-03-09
RS68104B1 (sr) 2026-06-30
SI3883647T1 (sl) 2026-04-30
MX2021005423A (es) 2021-09-08
IL283194A (en) 2021-06-30
JP7551610B2 (ja) 2024-09-17
IL283194B2 (en) 2025-03-01
FI3883647T3 (fi) 2026-03-25
JP2025000636A (ja) 2025-01-07
EP4737470A3 (en) 2026-07-22
PT3883647T (pt) 2026-02-26
DK3883647T3 (da) 2026-03-23
SG11202105227QA (en) 2021-06-29
PL3883647T3 (pl) 2026-06-01
US12552825B2 (en) 2026-02-17
EP4737470A2 (en) 2026-05-06
JP2022507776A (ja) 2022-01-18
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
HRP20260395T1 (hr) 2026-05-08
EP3883647A1 (en) 2021-09-29
KR20210133950A (ko) 2021-11-08
CA3120148A1 (en) 2020-05-28
US20230093692A1 (en) 2023-03-23
WO2020106627A1 (en) 2020-05-28
ES3063764T3 (en) 2026-04-20
BR112021009624A2 (pt) 2021-08-10
AU2019385333A1 (en) 2021-07-01
CN113573779A (zh) 2021-10-29

Similar Documents

Publication Publication Date Title
EP3664799B1 (en) Lincosamide antibiotics and uses thereof
US11535643B2 (en) Macrolides with modified desosamine sugars and uses thereof
US20260035402A1 (en) C10-alkylene substituted 13-membered macrolides and uses thereof
JP2025000636A (ja) C10-アルキレン置換された13員マクロライド及びそれらの使用
AU2023229518A1 (en) C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
US20230242565A1 (en) Macrolides with Modified Desosamine Sugars and Uses Thereof
EA052403B1 (ru) C10-алкилен-замещенные 13-членные макролиды и их применение
BR122025025362A2 (pt) Macrolídeos com 13 membros substituídos por c10-alquileno e usos dos mesmos
HK40063248A (en) C10-alkylene substituted 13-membered macrolides and uses thereof
HK40063711A (en) C11-cyclic substituted 13-membered macrolides and uses thereof
HK40029252B (en) Inhibitors of plasma kallikrein and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)